Drugs / rDEN1∆30 vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01084291 | Apr → May 2010 | dengue disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rDEN1∆30 vaccine | “rDEN1∆30 vaccine” NCT01084291 ↗ |
| Modality | Vaccine | “investigational vaccine for preventing infection with DEN1” NCT01084291 ↗ |
| Route | Subcutaneous | “Subcutaneous injection in upper arm of vaccine at dose of 10 plaque-forming units (PFU)” NCT01084291 ↗ |